BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

281 related articles for article (PubMed ID: 35405763)

  • 21. Clinical and genetic characterization of Epstein-Barr virus-associated T/NK-cell lymphoproliferative diseases.
    Luo H; Liu D; Liu W; Jin J; Bi X; Zhang P; Gu J; Zheng M; Xiao M; Liu X; Zhou J; Wang QF
    J Allergy Clin Immunol; 2023 Apr; 151(4):1096-1109. PubMed ID: 36423698
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinicopathological states of Epstein-Barr virus-associated T/NK-cell lymphoproliferative disorders (severe chronic active EBV infection) of children and young adults.
    Suzuki K; Ohshima K; Karube K; Suzumiya J; Ohga S; Ishihara S; Tamura K; Kikuchi M
    Int J Oncol; 2004 May; 24(5):1165-74. PubMed ID: 15067338
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Atypical hydroa vacciniforme-like epstein-barr virus associated T/NK-cell lymphoproliferative disorder.
    Lee HY; Baek JO; Lee JR; Park SH; Jeon IS; Roh JY
    Am J Dermatopathol; 2012 Dec; 34(8):e119-24. PubMed ID: 23169419
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Epstein-Barr Virus-Positive T/NK-Cell Lymphoproliferative Disorders Manifested as Gastrointestinal Perforations and Skin Lesions: A Case Report.
    Xiao HJ; Li J; Song HM; Li ZH; Dong M; Zhou XG
    Medicine (Baltimore); 2016 Feb; 95(5):e2676. PubMed ID: 26844502
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Diagnosis and management of EBV-positive lymphoproliferative disorders].
    Arai A
    Rinsho Ketsueki; 2023; 64(8):764-771. PubMed ID: 37673629
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Chronic active Epstein-Barr virus infection associated with hemophagocytic syndrome and extra-nodal natural killer/T-cell lymphoma in an 18-year-old girl: A case report.
    Xing Y; Yang J; Lian G; Chen S; Chen L; Li F
    Medicine (Baltimore); 2017 May; 96(19):e6845. PubMed ID: 28489771
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Epstein-Barr Virus-Associated T and NK-Cell Lymphoproliferative Diseases.
    Kim WY; Montes-Mojarro IA; Fend F; Quintanilla-Martinez L
    Front Pediatr; 2019; 7():71. PubMed ID: 30931288
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The Clinical Significance and Prognostic Role of Whole-Blood Epstein-Barr Virus DNA in Lymphoma-Associated Hemophagocytic Lymphohistiocytosis.
    Zhang J; Qin S; Jin Z; Chen Q; Xing L; Qiu T; Xia Y; Liang J; Zhu H; Wang L; Fan L; Xu W; Li J; Miao Y
    J Clin Immunol; 2023 Aug; 43(6):1302-1310. PubMed ID: 37093406
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Editorial: Epstein-Barr Virus-Associated T/NK-Cell Lymphoproliferative Diseases.
    Fujiwara S; Kimura H
    Front Pediatr; 2019; 7():285. PubMed ID: 31355168
    [No Abstract]   [Full Text] [Related]  

  • 30. Clinical application of Epstein-Barr virus DNA loads in Epstein-Barr virus-associated diseases: A cohort study.
    Yu S; Yang Q; Wu J; Zhu M; Ai J; Zhang H; Xu B; Shao L; Zhang W
    J Infect; 2021 Jan; 82(1):105-111. PubMed ID: 33248217
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Chronic Active Epstein-Barr Virus Infection With Central Nervous System Involvement in Children: A Clinical Study of 22 Cases.
    Ou W; Zhao Y; Wei A; Ma H; Zhang L; Lian H; Zhang Q; Chen S; Wang D; Li Z; Wang T; Zhang R
    Pediatr Infect Dis J; 2023 Jan; 42(1):20-26. PubMed ID: 36476521
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Diagnostic and disease severity determination criteria for hydroa vacciniforme lymphoproliferative disorders and severe mosquito bite allergy.
    Hirai Y; Asada H; Hamada T; Kawada JI; Kimura H; Arai A; Ohshima K; Ohga S; Iwatsuki K;
    J Dermatol; 2023 Jul; 50(7):e198-e205. PubMed ID: 37249004
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Epstein-Barr virus-associated T-/natural killer cell lymphoproliferative diseases.
    Yachie A; Kanegane H; Kasahara Y
    Semin Hematol; 2003 Apr; 40(2):124-32. PubMed ID: 12704589
    [TBL] [Abstract][Full Text] [Related]  

  • 34. NK-cell post-transplant lymphoproliferative disease with chronic active Epstein-Barr virus infection-like clinical findings.
    Iemura T; Kondo T; Hishizawa M; Yamashita K; Kimura H; Takaori-Kondo A
    Int J Infect Dis; 2019 Nov; 88():31-33. PubMed ID: 31398454
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Chronic Active Epstein-Barr Virus Infection of T/NK-Cell Type Mimicking Classic Hodgkin Lymphoma: Clinicopathologic and Genetic Features of 8 Cases Supporting a Variant With "Hodgkin/Reed-Sternberg-like" Cells of NK Phenotype.
    Chen Z; Liu W; Zhang W; Ye Y; Guan P; Gao L; Zhao S
    Am J Surg Pathol; 2019 Dec; 43(12):1611-1621. PubMed ID: 31305266
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [The understanding of Epstein-Barr virus associated lymphoproliferative disorder].
    Zhou XG; Zhang YL; Xie JL; Huang YH; Zheng YY; Li WS; Chen H; Liu F; Pan HX; Wei P; Wang Z; Hu YC; Yang KY; Xiao HL; Wu MJ; Yin WH; Mei KY; Chen G; Yan XC; Meng G; Xu G; Li J; Tian SF; Zhu J; Song YQ; Zhang WJ
    Zhonghua Bing Li Xue Za Zhi; 2016 Dec; 45(12):817-821. PubMed ID: 28056294
    [TBL] [Abstract][Full Text] [Related]  

  • 37. EBV associated T- and NK-cell lymphoproliferative diseases: A comprehensive overview of clinical manifestations and novel therapeutic insights.
    Shafiee A; Shamsi S; Kohandel Gargari O; Beiky M; Allahkarami MM; Miyanaji AB; Aghajanian S; Mozhgani SH
    Rev Med Virol; 2022 Jul; 32(4):e2328. PubMed ID: 35122349
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Rapid identification and characterization of infected cells in blood during chronic active Epstein-Barr virus infection.
    Fournier B; Boutboul D; Bruneau J; Miot C; Boulanger C; Malphettes M; Pellier I; Dunogué B; Terrier B; Suarez F; Blanche S; Castelle M; Winter S; Delecluse HJ; Molina T; Picard C; Ehl S; Moshous D; Galicier L; Barlogis V; Fischer A; Neven B; Latour S
    J Exp Med; 2020 Nov; 217(11):. PubMed ID: 32812031
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Novel mouse xenograft models reveal a critical role of CD4+ T cells in the proliferation of EBV-infected T and NK cells.
    Imadome K; Yajima M; Arai A; Nakazawa A; Kawano F; Ichikawa S; Shimizu N; Yamamoto N; Morio T; Ohga S; Nakamura H; Ito M; Miura O; Komano J; Fujiwara S
    PLoS Pathog; 2011 Oct; 7(10):e1002326. PubMed ID: 22028658
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The spectrum of Epstein-Barr virus-associated lymphoproliferative disease in Korea: incidence of disease entities by age groups.
    Cho EY; Kim KH; Kim WS; Yoo KH; Koo HH; Ko YH
    J Korean Med Sci; 2008 Apr; 23(2):185-92. PubMed ID: 18436998
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.